Literature DB >> 28636952

Human Leukocyte Antigen F Presents Peptides and Regulates Immunity through Interactions with NK Cell Receptors.

Charles L Dulberger1, Curtis P McMurtrey2, Angelique Hölzemer3, Karlynn E Neu4, Victor Liu1, Adriana M Steinbach1, Wilfredo F Garcia-Beltran5, Michael Sulak6, Bana Jabri7, Vincent J Lynch6, Marcus Altfeld8, William H Hildebrand2, Erin J Adams9.   

Abstract

Evidence is mounting that the major histocompatibility complex (MHC) molecule HLA-F (human leukocyte antigen F) regulates the immune system in pregnancy, infection, and autoimmunity by signaling through NK cell receptors (NKRs). We present structural, biochemical, and evolutionary analyses demonstrating that HLA-F presents peptides of unconventional length dictated by a newly arisen mutation (R62W) that has produced an open-ended groove accommodating particularly long peptides. Compared to empty HLA-F open conformers (OCs), HLA-F tetramers bound with human-derived peptides differentially stained leukocytes, suggesting peptide-dependent engagement. Our in vitro studies confirm that NKRs differentiate between peptide-bound and peptide-free HLA-F. The complex structure of peptide-loaded β2m-HLA-F bound to the inhibitory LIR1 revealed similarities to high-affinity recognition of the viral MHC-I mimic UL18 and a docking strategy that relies on contacts with HLA-F as well as β2m, thus precluding binding to HLA-F OCs. These findings provide a biochemical framework to understand how HLA-F could regulate immunity via interactions with NKRs.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HLA-F structure; KIR; LIR; MHC antigen presentation; MHC-I evolution; NK cell receptor; NK cell regulation

Mesh:

Substances:

Year:  2017        PMID: 28636952      PMCID: PMC5523829          DOI: 10.1016/j.immuni.2017.06.002

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  56 in total

1.  Thermal stability comparison of purified empty and peptide-filled forms of a class I MHC molecule.

Authors:  M L Fahnestock; I Tamir; L Narhi; P J Bjorkman
Journal:  Science       Date:  1992-12-04       Impact factor: 47.728

2.  The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC.

Authors:  D R Madden; J C Gorga; J L Strominger; D C Wiley
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

3.  Modeling amino acid substitution patterns in orthologous and paralogous genes.

Authors:  Gavin C Conant; Günter P Wagner; Peter F Stadler
Journal:  Mol Phylogenet Evol       Date:  2006-07-26       Impact factor: 4.286

4.  HLA-E-restricted regulatory CD8(+) T cells are involved in development and control of human autoimmune type 1 diabetes.

Authors:  Hong Jiang; Steve M Canfield; Mary P Gallagher; Hong H Jiang; Yihua Jiang; Zongyu Zheng; Leonard Chess
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

5.  The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.

Authors:  V Braud; E Y Jones; A McMichael
Journal:  Eur J Immunol       Date:  1997-05       Impact factor: 5.532

6.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

7.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 8.  Vital and vulnerable functions of the primate placenta critical for infant health and brain development.

Authors:  Christopher L Coe; Gabriele R Lubach
Journal:  Front Neuroendocrinol       Date:  2014-04-01       Impact factor: 8.606

9.  A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.

Authors:  M Colonna; F Navarro; T Bellón; M Llano; P García; J Samaridis; L Angman; M Cella; M López-Botet
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

10.  HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response-Implications on HSCT Outcome.

Authors:  Thomas Kraemer; Alexander A Celik; Trevor Huyton; Heike Kunze-Schumacher; Rainer Blasczyk; Christina Bade-Döding
Journal:  Stem Cells Int       Date:  2015-08-12       Impact factor: 5.443

View more
  38 in total

1.  KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behçet Disease.

Authors:  Harry Petrushkin; Paul J Norman; Emma Lougee; Peter Parham; Graham R Wallace; Miles R Stanford; Farida Fortune
Journal:  J Immunol       Date:  2019-08-12       Impact factor: 5.422

Review 2.  Conserved and variable natural killer cell receptors: diverse approaches to viral infections.

Authors:  Leidy Y Bastidas-Legarda; Salim I Khakoo
Journal:  Immunology       Date:  2019-01-17       Impact factor: 7.397

3.  HLA-F on Autologous HIV-Infected Cells Activates Primary NK Cells Expressing the Activating Killer Immunoglobulin-Like Receptor KIR3DS1.

Authors:  Zahra Kiani; Julie Bruneau; Daniel E Geraghty; Nicole F Bernard
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

Review 4.  Mutually assured destruction: the cold war between viruses and natural killer cells.

Authors:  Ayad Ali; Ivayla E Gyurova; Stephen N Waggoner
Journal:  Curr Opin Virol       Date:  2019-03-13       Impact factor: 7.090

Review 5.  A guide to antigen processing and presentation.

Authors:  Novalia Pishesha; Thibault J Harmand; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2022-04-13       Impact factor: 53.106

6.  Natural LILRB1 D1-D2 variants show frequency differences in populations and bind to HLA class I with various avidities.

Authors:  Fuguo Liu; Alexander T H Cocker; Jason L Pugh; Zakia Djaoud; Peter Parham; Lisbeth A Guethlein
Journal:  Immunogenetics       Date:  2022-05-13       Impact factor: 3.330

7.  An Ancient Fecundability-Associated Polymorphism Creates a GATA2 Binding Site in a Distal Enhancer of HLA-F.

Authors:  Katelyn M Mika; Xilong Li; Francesco J DeMayo; Vincent J Lynch
Journal:  Am J Hum Genet       Date:  2018-09-20       Impact factor: 11.025

Review 8.  Engineering universal cells that evade immune detection.

Authors:  Robert Lanza; David W Russell; Andras Nagy
Journal:  Nat Rev Immunol       Date:  2019-08-15       Impact factor: 53.106

9.  The Distinct Immune Nature of the Fetal Inflammatory Response Syndrome Type I and Type II.

Authors:  Robert Para; Roberto Romero; Derek Miller; Jose Galaz; Bogdan Done; Azam Peyvandipour; Meyer Gershater; Li Tao; Kenichiro Motomura; Douglas M Ruden; Jenna Isherwood; Eunjung Jung; Tomi Kanninen; Roger Pique-Regi; Adi L Tarca; Nardhy Gomez-Lopez
Journal:  Immunohorizons       Date:  2021-09-14

Review 10.  HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation.

Authors:  Burcu Duygu; Timo I Olieslagers; Mathijs Groeneweg; Christina E M Voorter; Lotte Wieten
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.